Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies

N/AUnknownNCT03319290

Data Collection Analysis Business Management2,000 enrolled

Overview

Observational study is to increase surveillance for breast and ovarian cancers, also to determine targeted risk-reducing and preventative strategies.

The general design of this study is collecting data and reviewing the Principal Investigators' (P.I.) Standard Operating Procedures (SOP) on BRCA testing and changes made to their specific SOP.

Study Type

OBSERVATIONAL

Enrollment

2,000

Conditions

Hereditary Cancer

Interventions

BRCA1 and BRCA2GENETIC

Genetic breast and ovarian cancer testing

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Must be a Medical Practitioner * Medical Doctor (MD) * Doctor of Osteopathic (DO) * Physician Assistant (PA) * Advanced Practice Registered Nurse (APRN) * Nurse Practitioner (NP) * Must have a current standard operating procedure that includes obtaining/reviewing medical history and family medical history Exclusion Criteria: * Government-funded insurance data cannot be included in the study.

Locations (1)

DCABM

Land O' Lakes, Florida, United States

Outcomes

Primary Outcomes

Provider Structures and Processes

Plan of Care Changes due to BRCA testing. Provider based observational survey system on the health and well-being of patients and populations

Time frame: 36 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.